Clinical Trial Update: Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM) [NA]

View source ↗

Summary

The SETAM study, sponsored by Biotronik France, completed evaluating early detection and active management of supraventricular arrhythmias using telecardiology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Atrial Tachycardia

Snippet

Sponsor: Biotronik France | Conditions: Atrial Fibrillation, Atrial Flutter | NA | Status: COMPLETED